
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $13.6M | -- | $30M | $27.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -7.72% | |
Cost of Revenues | -- | $13.8M | -- | $31.3M | $25.5M | |
Gross Profit | -- | -$213K | -- | -$1.3M | $2.2M | |
Gross Profit Margin | -- | -1.56% | -- | -4.35% | 7.91% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $10M | -- | $18.6M | $22.6M | |
Other Inc / (Exp) | -- | $371.3K | $2.6M | -$889.8K | $3.6K | |
Operating Expenses | -- | $10M | $2.9M | $18.3M | $22.6M | |
Operating Income | -- | -$10.2M | -$2.9M | -$19.6M | -$20.4M | |
Net Interest Expenses | -- | $264.7K | -- | $7.3M | $5.1M | |
EBT. Incl. Unusual Items | -- | -$10.1M | -$302.5K | -$27.8M | -$25.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $19.5K | -- | -$336K | -$134.9K | |
Net Income to Company | -- | -$10.1M | -$302.5K | -$27.5M | -$25.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$10.1M | -$302.5K | -$27.5M | -$25.3M | |
Basic EPS (Cont. Ops) | -- | -$0.49 | -$0.01 | -$1.32 | -$1.25 | |
Diluted EPS (Cont. Ops) | -- | -$0.49 | -$0.01 | -$1.32 | -$1.25 | |
Weighted Average Basic Share | -- | $20.9M | $20.9M | $21.4M | $20.3M | |
Weighted Average Diluted Share | -- | $20.9M | $20.9M | $21.4M | $20.3M | |
EBITDA | -- | -$7.7M | -$2.9M | -$16.6M | -$18.1M | |
EBIT | -- | -$9.8M | -$2.9M | -$20.5M | -$20.4M | |
Revenue (Reported) | -- | $13.6M | -- | $30M | $27.7M | |
Operating Income (Reported) | -- | -$10.2M | -$2.9M | -$19.6M | -$20.4M | |
Operating Income (Adjusted) | -- | -$9.8M | -$2.9M | -$20.5M | -$20.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $4.7M | $8.4M | $7.9M | $6.8M | |
Revenue Growth (YoY) | -- | -- | -- | -5.5% | -13.3% | |
Cost of Revenues | -- | $6M | $8.7M | $7.7M | $5.9M | |
Gross Profit | -- | -$1.3M | -$344.5K | $242.6K | $899.8K | |
Gross Profit Margin | -- | -26.38% | -4.12% | 3.07% | 13.14% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $3.9M | $4.2M | $7.2M | $3.8M | |
Other Inc / (Exp) | -- | $50K | -- | -- | -$11.1K | |
Operating Expenses | -- | $3.9M | $4.1M | $7.2M | $3.8M | |
Operating Income | -- | -$5.1M | -$4.4M | -$7M | -$2.9M | |
Net Interest Expenses | -- | $151.8K | $1.5M | $1.5M | $1.3M | |
EBT. Incl. Unusual Items | -- | -$5.2M | -$5.9M | -$8.4M | -$4.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $14.2K | -$120 | -- | -- | |
Net Income to Company | -- | -$5.2M | -$5.9M | -$8.4M | -$4.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$5.2M | -$5.9M | -$8.4M | -$4.2M | |
Basic EPS (Cont. Ops) | -- | -$0.25 | -$0.28 | -$0.49 | -$0.20 | |
Diluted EPS (Cont. Ops) | -- | -$0.25 | -$0.28 | -$0.49 | -$0.20 | |
Weighted Average Basic Share | -- | $20.9M | $20.9M | $17.1M | $21.4M | |
Weighted Average Diluted Share | -- | $20.9M | $20.9M | $17.1M | $21.4M | |
EBITDA | -- | -$4.4M | -$3.4M | -$6M | -$2.4M | |
EBIT | -- | -$5.1M | -$4.4M | -$7M | -$2.9M | |
Revenue (Reported) | -- | $4.7M | $8.4M | $7.9M | $6.8M | |
Operating Income (Reported) | -- | -$5.1M | -$4.4M | -$7M | -$2.9M | |
Operating Income (Adjusted) | -- | -$5.1M | -$4.4M | -$7M | -$2.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $29.5M | $26.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | $30.2M | $23.8M | |
Gross Profit | -- | -- | -- | -$716.7K | $2.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | $21.9M | $20.4M | |
Other Inc / (Exp) | -- | $50K | $50K | -$1M | -$9.1K | |
Operating Expenses | -- | -- | -- | $21.3M | $19.2M | |
Operating Income | -- | -- | -- | -$22.1M | -$16.3M | |
Net Interest Expenses | -- | $151.8K | $1.7M | $7.2M | $4.9M | |
EBT. Incl. Unusual Items | -- | -- | -- | -$30.3M | -$21.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -$335.9K | -- | |
Net Income to Company | -- | -- | -- | -$30M | -$21.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -$30M | -$21.1M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -$1.52 | -$0.99 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -$1.52 | -$0.99 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -$19.1M | -$14.5M | |
EBIT | -- | -- | -- | -$23.1M | -$16.4M | |
Revenue (Reported) | -- | -- | -- | $29.5M | $26.6M | |
Operating Income (Reported) | -- | -- | -- | -$22.1M | -$16.3M | |
Operating Income (Adjusted) | -- | -- | -- | -$23.1M | -$16.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $4.7M | $8.4M | $7.9M | $6.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $6M | $8.7M | $7.7M | $5.9M | |
Gross Profit | -- | -$1.3M | -$344.5K | $242.6K | $899.8K | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $3.9M | $4.2M | $7.2M | $3.8M | |
Other Inc / (Exp) | -- | $50K | -- | -- | -$11.1K | |
Operating Expenses | -- | $3.9M | $4.1M | $7.2M | $3.8M | |
Operating Income | -- | -$5.1M | -$4.4M | -$7M | -$2.9M | |
Net Interest Expenses | -- | $151.8K | $1.5M | $1.5M | $1.3M | |
EBT. Incl. Unusual Items | -- | -$5.2M | -$5.9M | -$8.4M | -$4.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $14.2K | -$120 | -- | -- | |
Net Income to Company | -- | -$5.2M | -$5.9M | -$8.4M | -$4.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$5.2M | -$5.9M | -$8.4M | -$4.2M | |
Basic EPS (Cont. Ops) | -- | -$0.25 | -$0.28 | -$0.49 | -$0.20 | |
Diluted EPS (Cont. Ops) | -- | -$0.25 | -$0.28 | -$0.49 | -$0.20 | |
Weighted Average Basic Share | -- | $20.9M | $20.9M | $17.1M | $21.4M | |
Weighted Average Diluted Share | -- | $20.9M | $20.9M | $17.1M | $21.4M | |
EBITDA | -- | -$4.4M | -$3.4M | -$6M | -$2.4M | |
EBIT | -- | -$5.1M | -$4.4M | -$7M | -$2.9M | |
Revenue (Reported) | -- | $4.7M | $8.4M | $7.9M | $6.8M | |
Operating Income (Reported) | -- | -$5.1M | -$4.4M | -$7M | -$2.9M | |
Operating Income (Adjusted) | -- | -$5.1M | -$4.4M | -$7M | -$2.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $2.9M | $680.8K | $7.6M | $653K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | $1.1M | -- | $1.8M | $2M | |
Inventory | -- | $6.1M | -- | $6.9M | $8M | |
Prepaid Expenses | -- | $436.2K | $236K | $845.9K | $1.1M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | $11.6M | $916.8K | $17.2M | $11.8M | |
Property Plant And Equipment | -- | $43.8M | -- | $46.5M | $45.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | $1.9M | -- | $1.9M | $1.9M | |
Other Intangibles | -- | -- | -- | -- | $319.3K | |
Other Long-Term Assets | -- | $46.5K | $178.5M | $169.7K | $169.7K | |
Total Assets | -- | $57.4M | $179.4M | $65.8M | $60M | |
Accounts Payable | -- | $7.2M | -- | $10.9M | $11.5M | |
Accrued Expenses | -- | -- | $842.5K | $3.4M | -- | |
Current Portion Of Long-Term Debt | -- | $3.2M | -- | $48M | $5.5M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | $609.2K | $594K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | $17.4M | $2.5M | $67.3M | $25.4M | |
Long-Term Debt | -- | $10M | -- | $16.5M | $25.1M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $29.3M | $2.5M | $87.1M | $60.7M | |
Common Stock | -- | -- | $178.5M | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | $28.1M | $176.9M | -$21.3M | -$695.9K | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | $28.1M | $176.9M | -$21.3M | -$695.9K | |
Total Liabilities and Equity | -- | $57.4M | $179.4M | $65.8M | $60M | |
Cash and Short Terms | -- | $2.9M | $680.8K | $7.6M | $653K | |
Total Debt | -- | $13.2M | $1.5M | $64.5M | $30.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | $12.7M | $8.2M | $192.5K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | $3M | $4.8M | $1.8M | |
Inventory | -- | -- | $7M | $6.8M | $7.8M | |
Prepaid Expenses | -- | -- | $1.6M | $2.4M | $848.4K | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | -- | $24.3M | $22.2M | $10.6M | |
Property Plant And Equipment | -- | -- | $46.8M | $46.1M | $45.3M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | $1.9M | $1.9M | $1.9M | |
Other Intangibles | -- | -- | -- | -- | $328.8K | |
Other Long-Term Assets | -- | -- | $171K | $169.7K | $254.7K | |
Total Assets | -- | -- | $73.2M | $70.3M | $58.4M | |
Accounts Payable | -- | -- | $8.5M | $7.2M | $13M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | $40.4M | $13.1M | $5.7M | |
Current Portion Of Capital Lease Obligations | -- | -- | $523.7K | $628.8K | $603.3K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | -- | $57.3M | $28.8M | $35.9M | |
Long-Term Debt | -- | -- | $13M | $22.2M | $24.9M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | $74.3M | $54.1M | $63.2M | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -$1.1M | $16.2M | -$4.8M | |
Total Liabilities and Equity | -- | -- | $73.2M | $70.3M | $58.4M | |
Cash and Short Terms | -- | -- | $12.7M | $8.2M | $192.5K | |
Total Debt | -- | -- | $53.4M | $35.3M | $30.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$10.1M | -$302.5K | -$27.5M | -$25.3M | |
Depreciation & Amoritzation | -- | $2.1M | -- | $3.9M | $2.3M | |
Stock-Based Compensation | -- | -- | -- | $492.3K | $1.3M | |
Change in Accounts Receivable | -- | -$765.9K | -- | $706K | -$213.2K | |
Change in Inventories | -- | -$3.4M | -- | -$649K | -$1.8M | |
Cash From Operations | -- | -$6.8M | -$2.1M | -$18M | -$15.1M | |
Capital Expenditures | -- | $21.2M | -- | $4.5M | $2M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$21.2M | -- | -$4.5M | -$1.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $11.3M | $1.5M | $42M | $10.6M | |
Long-Term Debt Repaid | -- | -$689K | -- | -$15.6M | -$566K | |
Repurchase of Common Stock | -- | -- | -- | -$159.5M | -- | |
Other Financing Activities | -- | -$1.7M | $163.1K | -$1.4M | -- | |
Cash From Financing | -- | $27.5M | $1.7M | $24.9M | $10M | |
Beginning Cash (CF) | -- | $3.4M | $1.1M | $5.1M | $7.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -$467.7K | -$442.6K | $2.5M | -$7M | |
Ending Cash (CF) | -- | $2.9M | $680.8K | $7.6M | $653K | |
Levered Free Cash Flow | -- | -$28M | -$2.1M | -$22.5M | -$17.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$5.2M | -$5.9M | -$8.4M | -$4.2M | |
Depreciation & Amoritzation | -- | $628K | $962K | $994.2K | $480.6K | |
Stock-Based Compensation | -- | $214.1K | $193.6K | $1.3M | $58.2K | |
Change in Accounts Receivable | -- | -$1.6M | -$450.6K | -$3.3M | $234.3K | |
Change in Inventories | -- | -$60K | -$726.4K | $99.1K | $421.2K | |
Cash From Operations | -- | -$4.6M | -$5.9M | -$6.8M | -$1.4M | |
Capital Expenditures | -- | $2.2M | $922K | $551K | $25.7K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$2.2M | -$922K | -$487.4K | -$25.7K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $15M | $8M | -- | |
Long-Term Debt Repaid | -- | -$130.9K | -$128.7K | -$147.7K | -$147.1K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $3.4M | -$500K | -- | $1.1M | |
Cash From Financing | -- | $4.3M | $14.4M | $7.9M | $937.9K | |
Beginning Cash (CF) | -- | $2.9M | $5.1M | $7.6M | $653K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -$2.5M | $7.5M | $595.4K | -$460.4K | |
Ending Cash (CF) | -- | $406.9K | $12.7M | $8.2M | $192.5K | |
Levered Free Cash Flow | -- | -$6.8M | -$6.8M | -$7.3M | -$1.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$30M | -$21.1M | |
Depreciation & Amoritzation | -- | -- | -- | $4M | $1.8M | |
Stock-Based Compensation | -- | $214.1K | $407.7K | $1.6M | $58.2K | |
Change in Accounts Receivable | -- | -- | -- | -$2.1M | $3.3M | |
Change in Inventories | -- | -- | -- | $176.5K | -$1.5M | |
Cash From Operations | -- | -- | -- | -$18.9M | -$9.7M | |
Capital Expenditures | -- | $2.2M | $3.1M | $4.1M | $1.4M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -$4M | -$1.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $35M | $2.6M | |
Long-Term Debt Repaid | -- | -- | -- | -$15.6M | -$565.3K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | $18.4M | $3.1M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -$4.5M | -$8M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -$23M | -$11.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$5.2M | -$5.9M | -$8.4M | -$4.2M | |
Depreciation & Amoritzation | -- | $628K | $962K | $994.2K | $480.6K | |
Stock-Based Compensation | -- | $214.1K | $193.6K | $1.3M | $58.2K | |
Change in Accounts Receivable | -- | -$1.6M | -$450.6K | -$3.3M | $234.3K | |
Change in Inventories | -- | -$60K | -$726.4K | $99.1K | $421.2K | |
Cash From Operations | -- | -$4.6M | -$5.9M | -$6.8M | -$1.4M | |
Capital Expenditures | -- | $2.2M | $922K | $551K | $25.7K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$2.2M | -$922K | -$487.4K | -$25.7K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $15M | $8M | -- | |
Long-Term Debt Repaid | -- | -$130.9K | -$128.7K | -$147.7K | -$147.1K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $3.4M | -$500K | -- | $1.1M | |
Cash From Financing | -- | $4.3M | $14.4M | $7.9M | $937.9K | |
Beginning Cash (CF) | -- | $2.9M | $5.1M | $7.6M | $653K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -$2.5M | $7.5M | $595.4K | -$460.4K | |
Ending Cash (CF) | -- | $406.9K | $12.7M | $8.2M | $192.5K | |
Levered Free Cash Flow | -- | -$6.8M | -$6.8M | -$7.3M | -$1.4M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.